{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:01:17Z","timestamp":1784919677044,"version":"3.55.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T00:00:00Z","timestamp":1723248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T00:00:00Z","timestamp":1723248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key Project of Science & Technology Development Fund of Tianjin Education Commission for Higher Education","award":["2023ZD021"],"award-info":[{"award-number":["2023ZD021"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>This study conducted molecular subtyping of biliary tract cancer patients based on 19 PANoptosis-related gene signatures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Through consensus clustering, patients were categorized into two subtypes, A and B. By integrating multi-omics data and clinical information from different cohorts, we elucidated the association between different subtypes of biliary tract cancer and patient prognosis, which correlated with the immune infiltration characteristics of patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>LASSO regression analysis was performed on the 19 gene signatures, and we constructed and validated a 9-gene risk score prognostic model that accurately predicts the overall survival rate of different biliary tract cancer patients. Additionally, we developed a predictive nomogram demonstrating the clinical utility and robustness of our model. Further analysis of the risk score-based immune landscape highlighted potential associations with immune cell infiltration, chemotherapy, and immune therapy response.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Our study provides valuable insights into personalized treatment strategies for biliary tract cancer, which are crucial for improving patient prognosis and guiding treatment decisions in clinical practice.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12072-024-10718-x","type":"journal-article","created":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T16:01:47Z","timestamp":1723305707000},"page":"1792-1803","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification of PANoptosis-relevant subgroups and predicting signature to evaluate the prognosis and immune landscape of patients with biliary tract cancer"],"prefix":"10.1007","volume":"18","author":[{"given":"Dongming","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenshuai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aomei","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huikai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3345-8005","authenticated-orcid":false,"given":"Hua","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,10]]},"reference":[{"issue":"1","key":"10718_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/hep.31410","volume":"73","author":"L Fabris","year":"2021","unstructured":"Fabris L, Sato K, Alpini G, Strazzabosco M. The tumor microenvironment in cholangiocarcinoma progression. Hepatology. 2021;73(1):75\u201385","journal-title":"Hepatology"},{"key":"10718_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2020.107517","volume":"210","author":"LJ Palmieri","year":"2020","unstructured":"Palmieri LJ, Lavol\u00e9 J, Dermine S, et al. The choice for the optimal therapy in advanced biliary tract cancers: chemotherapy, targeted therapies or immunotherapy. Pharmacol Ther. 2020;210: 107517","journal-title":"Pharmacol Ther"},{"issue":"Suppl 1","key":"10718_CR3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/hep.31278","volume":"73","author":"CJ O\u2019Rourke","year":"2021","unstructured":"O\u2019Rourke CJ, Munoz-Garrido P, Andersen JB. Molecular targets in cholangiocarcinoma. Hepatology. 2021;73(Suppl 1):62\u201374","journal-title":"Hepatology"},{"issue":"7","key":"10718_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.tcb.2011.03.007","volume":"21","author":"JM Gump","year":"2011","unstructured":"Gump JM, Thorburn A. Autophagy and apoptosis: what is the connection. Trends Cell Biol. 2011;21(7):387\u2013392","journal-title":"Trends Cell Biol"},{"issue":"2","key":"10718_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrm3735","volume":"15","author":"G Mari\u00f1o","year":"2014","unstructured":"Mari\u00f1o G, Niso-Santano M, Baehrecke EH, Kroemer G. Self-consumption: the interplay of autophagy and apoptosis. Nat Rev Mol Cell Biol. 2014;15(2):81\u201394","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"12","key":"10718_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.trecan.2017.10.006","volume":"3","author":"PJ Burke","year":"2017","unstructured":"Burke PJ. Mitochondria, bioenergetics and apoptosis in cancer. Trends Cancer. 2017;3(12):857\u2013870","journal-title":"Trends Cancer"},{"issue":"12","key":"10718_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41419-023-06370-2","volume":"14","author":"L Wang","year":"2023","unstructured":"Wang L, Zhu Y, Zhang L, et al. Mechanisms of PANoptosis and relevant small-molecule compounds for fighting diseases. Cell Death Dis. 2023;14(12):851","journal-title":"Cell Death Dis"},{"issue":"1","key":"10718_CR8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41420-023-01749-8","volume":"9","author":"JL Lu","year":"2023","unstructured":"Lu JL, Yu CX, Song LJ. Programmed cell death in hepatic fibrosis: current and perspectives. Cell Death Discov. 2023;9(1):449","journal-title":"Cell Death Discov"},{"issue":"11\u201312","key":"10718_CR9","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1007\/s10495-023-01886-6","volume":"28","author":"HR Zhang","year":"2023","unstructured":"Zhang HR, Li YP, Shi ZJ, et al. Triptolide induces PANoptosis in macrophages and causes organ injury in mice. Apoptosis. 2023;28(11\u201312):1646\u20131665","journal-title":"Apoptosis"},{"issue":"23","key":"10718_CR10","first-page":"00236","volume":"S1471\u20134914","author":"A Pandeya","year":"2023","unstructured":"Pandeya A, Kanneganti TD. Therapeutic potential of PANoptosis: innate sensors, inflammasomes, and RIPKs in PANoptosomes. Trends Mol Med. 2023;S1471\u20134914(23):00236\u201300238","journal-title":"Trends Mol Med"},{"issue":"2","key":"10718_CR11","doi-asserted-by":"publisher","first-page":"e2305361","DOI":"10.1002\/adma.202305361","volume":"36","author":"L Zhou","year":"2023","unstructured":"Zhou L, Lyu J, Liu F, Su Y, Feng L, Zhang X. Immunogenic PANoptosis-initiated cancer sono-immune reediting nanotherapy by iteratively boosting cancer immunity cycle. Adv Mater. 2023;36(2):e2305361","journal-title":"Adv Mater"},{"issue":"4","key":"10718_CR12","doi-asserted-by":"publisher","first-page":"569","DOI":"10.32604\/or.2023.028964","volume":"31","author":"X Shi","year":"2023","unstructured":"Shi X, Gao X, Liu W, et al. Construction of the panoptosis-related gene model and characterization of tumor microenvironment infiltration in hepatocellular carcinoma. Oncol Res. 2023;31(4):569\u2013590","journal-title":"Oncol Res"},{"issue":"1","key":"10718_CR13","doi-asserted-by":"publisher","first-page":"14519","DOI":"10.1038\/s41598-023-41670-9","volume":"13","author":"Y Wei","year":"2023","unstructured":"Wei Y, Lan C, Yang C, et al. Robust analysis of a novel PANoptosis-related prognostic gene signature model for hepatocellular carcinoma immune infiltration and therapeutic response. Sci Rep. 2023;13(1):14519","journal-title":"Sci Rep"},{"key":"10718_CR14","doi-asserted-by":"publisher","first-page":"1197152","DOI":"10.3389\/fimmu.2023.1197152","volume":"14","author":"F Song","year":"2023","unstructured":"Song F, Wang CG, Mao JZ, et al. PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma. Front Immunol. 2023;14:1197152","journal-title":"Front Immunol"},{"key":"10718_CR15","doi-asserted-by":"publisher","first-page":"1217654","DOI":"10.3389\/fonc.2023.1217654","volume":"13","author":"B Zhang","year":"2023","unstructured":"Zhang B, Huang B, Zhang X, et al. PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer. Front Oncol. 2023;13:1217654","journal-title":"Front Oncol"},{"key":"10718_CR16","doi-asserted-by":"publisher","first-page":"1115221","DOI":"10.3389\/fphar.2023.1115221","volume":"14","author":"S Wei","year":"2023","unstructured":"Wei S, Chen Z, Ling X, Zhang W, Jiang L. Comprehensive analysis illustrating the role of PANoptosis-related genes in lung cancer based on bioinformatic algorithms and experiments. Front Pharmacol. 2023;14:1115221","journal-title":"Front Pharmacol"},{"issue":"12","key":"10718_CR17","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1007\/s00262-023-03564-7","volume":"72","author":"Q Hu","year":"2023","unstructured":"Hu Q, Wang R, Zhang J, Xue Q, Ding B. Tumor-associated neutrophils upregulate PANoptosis to foster an immunosuppressive microenvironment of non-small cell lung cancer. Cancer Immunol Immunother. 2023;72(12):4293\u20134308","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"10718_CR18","doi-asserted-by":"publisher","first-page":"17956","DOI":"10.1038\/s41598-023-45005-6","volume":"13","author":"C Zhang","year":"2023","unstructured":"Zhang C, Xia J, Liu X, et al. Identifying prognostic genes related PANoptosis in lung adenocarcinoma and developing prediction model based on bioinformatics analysis. Sci Rep. 2023;13(1):17956","journal-title":"Sci Rep"},{"issue":"11","key":"10718_CR19","doi-asserted-by":"publisher","first-page":"9392","DOI":"10.3390\/ijms24119392","volume":"24","author":"Y Wang","year":"2023","unstructured":"Wang Y, Zhou J, Zhang N, et al. A novel defined PANoptosis-related miRNA signature for predicting the prognosis and immune characteristics in clear cell renal cell carcinoma: a miRNA signature for the prognosis of ccRCC. Int J Mol Sci. 2023;24(11):9392","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10718_CR20","doi-asserted-by":"publisher","first-page":"543","DOI":"10.32604\/or.2023.029563","volume":"31","author":"W Liu","year":"2023","unstructured":"Liu W, Qu C, Wang X. Comprehensive analysis of the role of immune-related PANoptosis lncRNA model in renal clear cell carcinoma based on RNA transcriptome and single-cell sequencing. Oncol Res. 2023;31(4):543\u2013567","journal-title":"Oncol Res"},{"issue":"12","key":"10718_CR21","doi-asserted-by":"crossref","first-page":"11163","DOI":"10.18632\/aging.103528","volume":"12","author":"R Malireddi","year":"2020","unstructured":"Malireddi R, Tweedell RE, Kanneganti TD. PANoptosis components, regulation, and implications. Aging (Albany NY). 2020;12(12):11163\u201311164","journal-title":"Aging (Albany NY)"},{"key":"10718_CR22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3389\/fcimb.2019.00406","volume":"9","author":"R Malireddi","year":"2019","unstructured":"Malireddi R, Kesavardhana S, Kanneganti TD. ZBP1 and TAK1: Master Regulators of NLRP3 inflammasome\/pyroptosis, apoptosis, and necroptosis (PAN-optosis). Front Cell Infect Microbiol. 2019;9:406","journal-title":"Front Cell Infect Microbiol"},{"issue":"12","key":"10718_CR23","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.136720","volume":"5","author":"R Karki","year":"2020","unstructured":"Karki R, Sharma BR, Lee E, et al. Interferon regulatory factor 1 regulates PANoptosis to prevent colorectal cancer. JCI Insight. 2020;5(12): e136720","journal-title":"JCI Insight"},{"key":"10718_CR24","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3389\/fcimb.2020.00238","volume":"10","author":"P Samir","year":"2020","unstructured":"Samir P, Malireddi R, Kanneganti TD. The PANoptosome: a deadly protein complex driving pyroptosis, apoptosis, and necroptosis (PANoptosis). Front Cell Infect Microbiol. 2020;10:238","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"10718_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009358","volume":"17","author":"B Briard","year":"2021","unstructured":"Briard B, Malireddi R, Kanneganti TD. Role of inflammasomes\/pyroptosis and PANoptosis during fungal infection. PLoS Pathog. 2021;17(3): e1009358","journal-title":"PLoS Pathog"},{"issue":"7","key":"10718_CR26","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/ijc.33698","volume":"149","author":"M Jiang","year":"2021","unstructured":"Jiang M, Qi L, Li L, Wu Y, Song D, Li Y. Caspase-8: A key protein of cross-talk signal way in \u201cPANoptosis\u201d in cancer. Int J Cancer. 2021;149(7):1408\u20131420","journal-title":"Int J Cancer"},{"issue":"7876","key":"10718_CR27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41586-021-03875-8","volume":"597","author":"S Lee","year":"2021","unstructured":"Lee S, Karki R, Wang Y, Nguyen LN, Kalathur RC, Kanneganti TD. AIM2 forms a complex with pyrin and ZBP1 to drive PANoptosis and host defence. Nature. 2021;597(7876):415\u2013419","journal-title":"Nature"},{"key":"10718_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mib.2020.07.012","volume":"59","author":"DE Place","year":"2021","unstructured":"Place DE, Lee S, Kanneganti TD. PANoptosis in microbial infection. Curr Opin Microbiol. 2021;59:42\u201349","journal-title":"Curr Opin Microbiol"},{"issue":"4","key":"10718_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167249","volume":"434","author":"LN Nguyen","year":"2022","unstructured":"Nguyen LN, Kanneganti TD. PANoptosis in viral infection: the missing puzzle piece in the cell death field. J Mol Biol. 2022;434(4): 167249","journal-title":"J Mol Biol"},{"issue":"10","key":"10718_CR30","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1007\/s10620-019-06011-9","volume":"65","author":"M Kinoshita","year":"2020","unstructured":"Kinoshita M, Kobayashi S, Gotoh K, et al. Heterogeneity of treg\/Th17 according to cancer progression and modification in biliary tract cancers via self-producing cytokines. Dig Dis Sci. 2020;65(10):2937\u20132948","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10718_CR31","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/hep.32317","volume":"77","author":"Y Shiode","year":"2023","unstructured":"Shiode Y, Kodama T, Shigeno S, et al. TNF receptor-related factor 3 inactivation promotes the development of intrahepatic cholangiocarcinoma through NF-\u03baB-inducing kinase-mediated hepatocyte transdifferentiation. Hepatology. 2023;77(2):395\u2013410","journal-title":"Hepatology"},{"key":"10718_CR32","first-page":"2360","volume":"6","author":"ZH Liu","year":"1864","unstructured":"Liu ZH, Lian BF, Dong QZ, et al. 2018 Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity. Biochim Biophys Acta Mol Basis Dis. 1864;6:2360\u20132368","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"2","key":"10718_CR33","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41417-023-00705-z","volume":"31","author":"YR Pan","year":"2024","unstructured":"Pan YR, Lai JC, Huang WK, et al. PLK1 and its substrate MISP facilitate intrahepatic cholangiocarcinoma progression by promoting lymphatic invasion and impairing E-cadherin adherens junctions. Cancer Gene Ther. 2024;31(2):322\u2013333","journal-title":"Cancer Gene Ther"},{"key":"10718_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108170","volume":"237","author":"D Lavacchi","year":"2022","unstructured":"Lavacchi D, Caliman E, Rossi G, et al. Ivosidenib in IDH1-mutated cholangiocarcinoma: clinical evaluation and future directions. Pharmacol Ther. 2022;237: 108170","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10718_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/hep.32258","volume":"75","author":"G Sapisochin","year":"2022","unstructured":"Sapisochin G, Ivanics T, Heimbach J. Liver Transplantation for intrahepatic cholangiocarcinoma: ready for prime time. Hepatology. 2022;75(2):455\u2013472","journal-title":"Hepatology"},{"key":"10718_CR36","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.omtn.2023.07.010","volume":"33","author":"X Yi","year":"2023","unstructured":"Yi X, Li J, Zheng X, et al. Construction of PANoptosis signature: novel target discovery for prostate cancer immunotherapy. Mol Ther Nucleic Acids. 2023;33:376\u2013390","journal-title":"Mol Ther Nucleic Acids"},{"issue":"12","key":"10718_CR37","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s41423-023-01107-9","volume":"20","author":"S Oh","year":"2023","unstructured":"Oh S, Lee J, Oh J, et al. Integrated NLRP3, AIM2, NLRC4, pyrin inflammasome activation and assembly drive PANoptosis. Cell Mol Immunol. 2023;20(12):1513\u20131526","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"10718_CR38","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s00018-022-04564-z","volume":"79","author":"Y Wang","year":"2022","unstructured":"Wang Y, Pandian N, Han JH, et al. Single cell analysis of PANoptosome cell death complexes through an expansion microscopy method. Cell Mol Life Sci. 2022;79(10):531","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10718_CR39","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004031","volume":"10","author":"L Nicol\u00e8","year":"2022","unstructured":"Nicol\u00e8 L, Sanavia T, Cappellesso R, et al. Necroptosis-driving genes RIPK1, RIPK3 and MLKL-p are associated with intratumoral CD3(+) and CD8(+) T cell density and predict prognosis in hepatocellular carcinoma. J Immunother Cancer. 2022;10(3): e004031","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10718_CR40","doi-asserted-by":"publisher","first-page":"11743","DOI":"10.1038\/s41598-021-89977-9","volume":"11","author":"T Lomphithak","year":"2021","unstructured":"Lomphithak T, Akara-Amornthum P, Murakami K, et al. Tumor necroptosis is correlated with a favorable immune cell signature and programmed death-ligand 1 expression in cholangiocarcinoma. Sci Rep. 2021;11(1):11743","journal-title":"Sci Rep"},{"issue":"4","key":"10718_CR41","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.jhep.2021.05.018","volume":"75","author":"X Song","year":"2021","unstructured":"Song X, Xu H, Wang P, et al. Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation. J Hepatol. 2021;75(4):888\u2013899","journal-title":"J Hepatol"},{"key":"10718_CR42","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13046-016-0318-y","volume":"35","author":"H Hong","year":"2016","unstructured":"Hong H, He C, Zhu S, et al. CCR7 mediates the TNF-\u03b1-induced lymphatic metastasis of gallbladder cancer through the \u201cERK1\/2 - AP-1\u201d and \u201cJNK - AP-1\u201d pathways. J Exp Clin Cancer Res. 2016;35:51","journal-title":"J Exp Clin Cancer Res"},{"key":"10718_CR43","doi-asserted-by":"publisher","first-page":"1210456","DOI":"10.3389\/fcell.2023.1210456","volume":"11","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zhang F, Pang P, et al. Identification of PANoptosis-relevant subgroups to evaluate the prognosis and immune landscape of patients with liver hepatocellular carcinoma. Front Cell Dev Biol. 2023;11:1210456","journal-title":"Front Cell Dev Biol"},{"key":"10718_CR44","doi-asserted-by":"publisher","first-page":"1218661","DOI":"10.3389\/fimmu.2023.1218661","volume":"14","author":"J Zhu","year":"2023","unstructured":"Zhu J, Huang Q, Peng X, et al. Identification of molecular subtypes based on PANoptosis-related genes and construction of a signature for predicting the prognosis and response to immunotherapy response in hepatocellular carcinoma. Front Immunol. 2023;14:1218661","journal-title":"Front Immunol"},{"issue":"5","key":"10718_CR45","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cell.2004.05.004","volume":"117","author":"F Martinon","year":"2004","unstructured":"Martinon F, Tschopp J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. Cell. 2004;117(5):561\u2013574","journal-title":"Cell"},{"issue":"1","key":"10718_CR46","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-018-0928-4","volume":"18","author":"X Jiang","year":"2019","unstructured":"Jiang X, Wang J, Deng X, et al. Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape. Mol Cancer. 2019;18(1):10","journal-title":"Mol Cancer"},{"key":"10718_CR47","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2019.11.009","volume":"470","author":"X Lei","year":"2020","unstructured":"Lei X, Lei Y, Li JK, et al. Immune cells within the tumor microenvironment: Biological functions and roles in cancer immunotherapy. Cancer Lett. 2020;470:126\u2013133","journal-title":"Cancer Lett"},{"issue":"6","key":"10718_CR48","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.immuni.2016.06.001","volume":"44","author":"JM Pitt","year":"2016","unstructured":"Pitt JM, V\u00e9tizou M, Daill\u00e8re R, et al. Resistance mechanisms to immune-checkpoint blockade in cancer: tumor-intrinsic and -extrinsic factors. Immunity. 2016;44(6):1255\u20131269","journal-title":"Immunity"},{"issue":"1","key":"10718_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/bjc.2017.434","volume":"118","author":"RW Jenkins","year":"2018","unstructured":"Jenkins RW, Barbie DA, Flaherty KT. Mechanisms of resistance to immune checkpoint inhibitors. Br J Cancer. 2018;118(1):9\u201316","journal-title":"Br J Cancer"},{"issue":"1","key":"10718_CR50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","volume":"20","author":"A Kalbasi","year":"2020","unstructured":"Kalbasi A, Ribas A. Tumour-intrinsic resistance to immune checkpoint blockade. Nat Rev Immunol. 2020;20(1):25\u201339","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"10718_CR51","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12935-023-03135-x","volume":"23","author":"L Heczko","year":"2023","unstructured":"Heczko L, Hlav\u00e1\u010d V, Hol\u00fd P, et al. Prognostic potential of whole exome sequencing in the clinical management of metachronous colorectal cancer liver metastases. Cancer Cell Int. 2023;23(1):295","journal-title":"Cancer Cell Int"},{"issue":"19","key":"10718_CR52","doi-asserted-by":"publisher","first-page":"10549","DOI":"10.18632\/aging.205094","volume":"15","author":"B Zhang","year":"2023","unstructured":"Zhang B, Chen X, Wang Z, et al. Identifying endoplasmic reticulum stress-related molecular subtypes and prognostic model for predicting the immune landscape and therapy response in pancreatic cancer. Aging (Albany NY). 2023;15(19):10549\u201310579","journal-title":"Aging (Albany NY)"},{"key":"10718_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114046","volume":"203","author":"D Zhang","year":"2024","unstructured":"Zhang D, Dorman K, Westphalen CB, et al. Unresectable biliary tract cancer: current and future systemic therapy. Eur J Cancer. 2024;203: 114046","journal-title":"Eur J Cancer"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10718-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-024-10718-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-024-10718-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T05:40:39Z","timestamp":1733895639000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-024-10718-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,10]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["10718"],"URL":"https:\/\/doi.org\/10.1007\/s12072-024-10718-x","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,10]]},"assertion":[{"value":"24 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"This study was approved by the Institutional Research Ethics Committees of the Tianjin Medical University Cancer Institute and Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}